Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ELIL vs. LABD: which is better?

Bottom line

ELIL vs LABD: the short answer

ELIL (Direxion Daily LLY Bull 2X ETF) and LABD (Direxion Daily S&P Biotech Bear 3X ETF) are both etfs.

Both charge the same expense ratio (1.07%).

Updated Nov 19, 2026

ELIL vs LABD side by side

ELILLABD
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio1.07%1.07%
Annual cost per $10k$107$107
10-yr cost on $10k (prospectus)$1,558$1,316
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—−70.0%
5-yr return (annualized)—−37.7%
10-yr return (annualized)—−54.4%
Best quarter—+75.0%
Worst quarter—−75.2%
Net assets (fund)$18.3M$54.2M
Number of holdings910
Portfolio turnover%%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

8 of ELIL's top 9 holdings also appear in LABD's top 10.

Shared top holdings
HoldingELILLABD
Goldman Sachs Liq Es Fd A32.52%26.30%
Dreyfus25.97%18.03%
Dreyfus15.35%40.47%
Goldman Financial14.01%52.74%
N/a0.82%-6.37%
N/a0.17%-6.37%
N/a-2.96%-6.37%
N/a-4.85%-6.37%

Source: SEC Form N-PORT

ELIL top 10

  1. Goldman Sachs Liq Es Fd A — 32.52%
  2. Dreyfus — 25.97%
  3. Dreyfus — 15.35%
  4. Eli Lilly & Company — 15.09%
  5. Goldman Financial — 14.01%
  6. N/a — 0.82%
  7. N/a — 0.17%
  8. N/a — -2.96%
  9. N/a — -4.85%

LABD top 10

  1. Goldman Financial — 52.74%
  2. Dreyfus — 40.47%
  3. Goldman Sachs Liq Es Fd A — 26.30%
  4. Dreyfus — 18.03%
  5. N/a — 2.98%
  6. N/a — 1.43%
  7. N/a — -1.55%
  8. N/a — -4.11%
  9. N/a — -4.88%
  10. N/a — -6.37%

FAQ

What is the difference between ELIL and LABD?
ELIL (Direxion Daily LLY Bull 2X ETF) and LABD (Direxion Daily S&P Biotech Bear 3X ETF) are both etfs. Both charge the same expense ratio (1.07%).
Which is cheaper, ELIL or LABD?
ELIL has the lower expense ratio (1.07%).
Should I own both ELIL and LABD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.